leisure time -WSS

leisure time

author：comprehensive 2025-10-01 12:12:05 - browse：85347

Home health and hospice chain Amedisys has chosen a new corporate owner.

Amedisys and UnitedHealth Group’s Optum agreed to a deal Monday in which UnitedHealth will pay $101 per share in cash for Amedisys, totaling $3.3 billion. UnitedHealth’s latest offer is $1 per share higher than what it proposed in its unsolicited buyout offer a few weeks ago.

Option Care Health, a company that delivers intravenous medicines and mails health care supplies to people’s homes, originally offered to acquire Amedisys in May in an all-stock deal. However, the attractiveness of that deal deteriorated after Option Care’s stock price plummeted soon after the company made its bid.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Activists slam private health insurers over coverage restrictions
Next article： First recipient of genetically engineered pig kidney has died

WSS

Shionogi licenses Pompe disease therapy from Maze Therapeutics

Senators push IRS to launch nonprofit hospital probe

Making AI in medicine accessible to smaller, and rural hospitals

H5N1 communication has been strictly for the birds

Making AI in medicine accessible to smaller, and rural hospitals

Bird flu outbreak in cows is latest avian flu curveball

focus

leisure time

entertainment

What does generative AI mean for health care? We asked experts

After Optum profits sink, UnitedHealth makes changes

State Dept. review finds Biden bears some blame for Afghanistan failures

Sanofi strikes deal with Novavax, boosting the vaccine maker

Jerome Adams on the need for new antivirals for Covid

Dairy farmers resist CDC push for PPE against bird flu virus

United colonoscopy coverage change 'may cost lives,' doctors say

BMS, looking to build heart drug business, turns to AI for diagnosis

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

Surge in Apellis stock fueled by confidence in safety of its eye drug

entertainment

Treatments for cramps don't cut it. Why aren't there better options?

H5N1 bird flu: what we're starting to learn about infection in cows

Dozens dead from Maui wildfires: What we know about the victims

Aspartame and sugar

After Optum profits sink, UnitedHealth makes changes

Mark Cuban is blaming the wrong people for high drug costs

knowledge

explore

hotspot

Wikipedia